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Background: We have previously shown that the risk of fatal and non-fatal cardiovascular events in diabetic individuals without overt 
cardiovascular (CV) disease is strongly related to number of CV risk factors, but it is unknown whether preclinical left ventricular (LV) abnormalities 
parallel the risk factor burden and contribute to its prognostic impact.
Methods: We assessed cardiovascular risk factors (male gender, smoking, hypertension, LDL >100, urinary albumin/creatinine >300, HDL <40, 
triglycerides >150, fibrinogen >352 and diabetes duration >20 years) and echocardiographic measures of LV structure and function as well as 
subsequent fatal/non-fatal CV events in 1374 diabetic participants in the 2nd Strong Heart Study examination.
Results: Compared to participants with 0-1 risk factor, those with 2-3 (n=449), 4-5 (n=516) or 6-9 (n=187) risk factors were at 2-fold (95% CI 
1.1-3.9, p=0.029), 2.8-fold (1.5-5.3, p=0.002) and 5.4-fold (2.8-10.4, p<0.001) increased risk of CV events in a Cox model adjusting for age. 
There was a modest parallel increase in the prevalence of LV hypertrophy (23%, 23%, 27% and 34%, p <0.05) and more pronounced increases in 
prevalences of low LV ejection fraction (8%, 10%, 12% and 20%, p=0.04), low stress-corrected LV midwall shortening (4%, 9%, 12% and 19%, p 
<0.001) and of LV wall motion abnormalities (6%, 6%, 8% and 13%, p <0.04). Additional Cox model showed that both higher LV mass index and 
lower ejection fraction strongly predicted CV events with only minimal attenuation of the hazard ratios for the risk factor groups (2.0 [p=0.032], 2.6 
[p=0.003] and 4.6 [p <0.001]).
Conclusions: Among diabetic individuals with documented CV disease the rate of CV events is strongly related to the number of concomitant 
risk factors, which are in turn related to greater prevalences of LV dysfunction and hypertrophy. The predictive values of risk factor burden and LV 
preclinical disease are additive, indicating that evaluation of both enhances stratification of risk in diabetes. 
